Cargando…
Current State and Innovations in Newborn Screening: Continuing to Do Good and Avoid Harm
In 1963, Robert Guthrie’s pioneering work developing a bacterial inhibition assay to measure phenylalanine in dried blood spots, provided the means for whole-population screening to detect phenylketonuria in the USA. In the following decades, NBS became firmly established as a part of public health...
Autores principales: | la Marca, Giancarlo, Carling, Rachel. S., Moat, Stuart. J., Yahyaoui, Raquel, Ranieri, Enzo, Bonham, James. R., Schielen, Peter. C. J. I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057559/ https://www.ncbi.nlm.nih.gov/pubmed/36975853 http://dx.doi.org/10.3390/ijns9010015 |
Ejemplares similares
-
Towards Achieving Equity and Innovation in Newborn Screening across Europe
por: Sikonja, Jaka, et al.
Publicado: (2022) -
Newborn Screening for Lysosomal Storage Disorders: Methodologies for Measurement of Enzymatic Activities in Dried Blood Spots
por: Gelb, Michael H., et al.
Publicado: (2018) -
2023 APHL/ISNS Newborn Screening Symposium
por: Olney, Richard S., et al.
Publicado: (2023) -
Raising Awareness of False Positive Newborn Screening Results Arising from Pivalate-Containing Creams and Antibiotics in Europe When Screening for Isovaleric Acidaemia
por: Bonham, James R., et al.
Publicado: (2018) -
The Washing Out Plan—The Good It Fails to Do, the Harm It Does
por: Haig, Alexander
Publicado: (1903)